<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>1 </plain></SENT>
<SENT sid="1" pm="."><plain>Experimental <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> induced by <z:hpo ids='HP_0002138'>subarachnoid haemorrhage</z:hpo> (SAH) in rabbits was studied in order to evaluate the efficacy of repeated i.v. infusion of Iloprost (ILO) </plain></SENT>
<SENT sid="2" pm="."><plain>2 </plain></SENT>
<SENT sid="3" pm="."><plain>The mean diameter of the basilar artery of intact animals was calculated as 737.5 +/- 52.8 microns while this value was reduced to 237.5 +/- 22.96 microns after SAH </plain></SENT>
<SENT sid="4" pm="."><plain>3 </plain></SENT>
<SENT sid="5" pm="."><plain>In the ILO treated group the mean diameter of the basilar artery was significantly increased and found to be 593.75 +/- 64.0 microns </plain></SENT>
<SENT sid="6" pm="."><plain>4 </plain></SENT>
<SENT sid="7" pm="."><plain>No change was observed in intracranial pressure (ICP) except a slight decrease in mean arterial pressure when relatively higher doses of ILO were used </plain></SENT>
<SENT sid="8" pm="."><plain>5 </plain></SENT>
<SENT sid="9" pm="."><plain>These results were taken as evidence of the high therapeutic value and low side effects of ILO in the treatment of persisting <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> due to SAH </plain></SENT>
</text></document>